Skip to content

Plexus PLXS Payments for Repurchase of Common Stock

Payments for Repurchase of Common Stock at other companies

Nordson logo
NordsonNDSN
Revvity logo
RevvityRVTY

Other financials

Income statement

See full
Revenue$1.2M+18.7%
Gross profit-$1.0B-18.4%
Operating income$61.8M+26.7%
Net income$49.8M+27.5%
EPS (diluted)$1.82+29.1%

Balance sheet

See full
Cash & equivalents$303.1M-2.4%
Total debt$77.5M-8.4%
Total equity$1.5B+10.2%
Total assets$3.4B+8.9%

Cash flow

See full
Operating cash flow$28.5M-22.4%
CapEx$12.5M-38.3%
Free cash flow-$50.6M-287%

Valuation

See full
Market cap$8.03B+98.0%
Enterprise value$7.8B+105%
P/E42.8×+14.4×
P/S+1.0×

Profitability

See full
Gross margin3.9%-6.1pp
Operating margin5.5%+0.8pp
Net margin4.6%+1.0pp
FCF margin1.9%-8.2pp

Returns & leverage

See full
Return on equity13.2%+2.3pp
Debt / equity0.1×0.0×
Current ratio1.5×0.0×

Where this comes from

Reported directly by Plexus in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.

The official record: Plexus’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Plexus's payments for repurchase of common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Plexus's payments for repurchase of common stock?
Plexus (PLXS) reported payments for repurchase of common stock of $21.04M in Q1 2026.
How has Plexus's payments for repurchase of common stock changed year-over-year?
Plexus's payments for repurchase of common stock increased by 67.7% year-over-year, from $12.54M to $21.04M.
What is the long-term trend for Plexus's payments for repurchase of common stock?
Over 4 years (2021 to 2025), Plexus's payments for repurchase of common stock has grown at a -11.9% compound annual growth rate (CAGR), from $108.45M to $65.34M.
What does payments for repurchase of common stock mean?
Reflects the cash spent by the company to buy back its own shares from the open market. This is a key component of capital allocation, often used to return excess cash to shareholders and offset dilution from equity-based compensation.